News
Researchers identified a unique protein signature in the blood of BMD and LGMD patients that may reflect disease progression.
Summer can be rough for folks with muscular dystrophy, columnist Patrick Moeschen writes, but it can also bring adventures in appreciation.
Ifetroban improved heart function and reduced cardiac damage biomarkers in people with DMD in a Phase 2 clinical trial.
For the second time, a person with DMD has died of acute liver failure after being treated with the one-time gene therapy Elevidys.
The FDA granted platform technology designation to the viral vector used in the LGMD2E gene therapy SRP-9003.
Caregiving means that columnist Betty Vertin sometimes misses out on activities with her children who don't have DMD. Finding balance is key.
The U.S. Food and Drug Administration (FDA) is due to convene an advisory committee meeting next month to review the data on deramiocel, an experimental cell therapy up for approval to treat heart ...
Patients are often the best experts on their disease, but what about emergency situations? Columnist Patrick Moeschen shares his thoughts.
Columnist Robin Stemple marks two anniversaries that forever altered his life. Despite the incredible challenges, he feels blessed.
Muscular dystrophy News, a property within the Bionews network of rare disease websites, is a community dedicated to providing resources for people living with muscular dystrophy and their care ...
A recent concert in Singapore was all about finding harmony through the talents that unite us in life, writes columnist Shalom Lim.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results